Generation Bio Co (GBIO)

Generation Bio Stock (GBIO) dropped by 50.21% from $2.41 to $1.20 in the trading on Thursday October 19, 2023. The reason why GBIO stock down today is due to the downgrade from analyst. TD Cowen downgraded the genetic medicines company to Market Perform from Outperform, citing a delay for the company’s lead program in hemophilia A. The downgrade comes after the Cambridge, Massachusetts-based biotech announced the development of a novel compound called immune-quiet DNA (iqDNA), which it expects to use in its lead hemophilia A program and other programs.